Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ventyx is a biopharmaceutical company focused on advancing oral therapies for patients living with autoimmune and inflammatory disorders.
Elektrofi develops hyper concentration microparticle technology for subcutaneous biologic medicine delivery.
Inspirato is a luxury travel and lifestyle subscription company.
Day One Biopharmaceuticals develops targeted therapies to treat people with life-threatening diseases.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.
CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.
P3 Health Partners is a patient-centered, physician-led and population health-focused healthcare company.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Stoke is developing antisense oligonucleotide medicines that target RNA splicing to increase gene expression for treatment.
Akero Therapeutics is a biotechnology company focused on reversing the NASH epidemic by restoring the body’s metabolism to a balanced state.
Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.
ProfoundBio is a developer of targeted therapeutics intended for patients with cancer.
Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.
Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.
Entact Bio is a biotechnology company that is in the preclinical stages of developing medications to improve protein function.
Verve Therapeutics is a clinical-stage biotechnology company developing genetic medicines for cardiovascular disease.
Gracell Biotechnologies is a developer of cancer immune therapy designed to treat cancer.
Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Loadsmart is a next-gen freight technology platform and 4PL that lower costs, increase efficiency, and digitize transportation for Shippers.
Janus Henderson Investors has invested in 227 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Therapeutics, Life Science, Medical. The firm invests across 24 different industry categories.
Among tracked funding rounds, Akero Therapeutics received $366.9M in a Post Ipo Equity round. Janus Henderson Investors's total known invested capital is $35.8B.
Janus Henderson Investors's average investment size is $153.6M across its portfolio of 227 companies.
Recent Janus Henderson Investors portfolio additions include Ventyx Biosciences, Elektrofi, Inspirato, Day One Biopharmaceuticals, Scorpion Therapeutics. These companies were founded in 2020 or later.